UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Diabetes care, 1997-04, Vol.20 (4), p.614-620

1997

Volltextzugriff (PDF)

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

European heart journal, 2003-06, Vol.24 (11), p.987-1003

2003

Volltextzugriff (PDF)

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

Diabetes care, 1998-03, Vol.21 (3), p.360-367

1998

Volltextzugriff (PDF)

Diabetes, prediabetes and cancer mortality

Diabetologia, 2010-09, Vol.53 (9), p.1867-1876

2010

Volltextzugriff (PDF)

Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

Arteriosclerosis, thrombosis, and vascular biology, 2000-02, Vol.20 (2), p.538-544

2000

Volltextzugriff (PDF)

Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men : The 22-year follow-up results of the Helsinki Policemen Study

Circulation (New York, N.Y.), 1998-08, Vol.98 (5), p.398-404

1998

Volltextzugriff (PDF)

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.72-77

2007

Volltextzugriff (PDF)

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose

European heart journal, 2002-08, Vol.23 (16), p.1267-1275

2002

Volltextzugriff (PDF)

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

The New England journal of medicine, 1998-07, Vol.339 (4), p.229-234

1998

Volltextzugriff (PDF)

Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study

Diabetes care, 2000-08, Vol.23 (8), p.1097-1102

2000

Volltextzugriff (PDF)

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme

European heart journal, 2001-04, Vol.22 (7), p.554-572

EUROASPIRE II Study Group

2001

Volltextzugriff (PDF)

Relationship between body mass index and mortality among Europeans

European journal of clinical nutrition, 2012-02, Vol.66 (2), p.156-165

2012

Volltextzugriff (PDF)

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes

Diabetologia, 2000-02, Vol.43 (2), p.148-155

2000

Volltextzugriff (PDF)

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

Diabetes (New York, N.Y.), 1994-08, Vol.43 (8), p.960-967

1994

Volltextzugriff (PDF)

Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men

Circulation (New York, N.Y.), 1999-07, Vol.100 (2), p.123-128

1999

Volltextzugriff (PDF)

Impact of Diabetes on Mortality After the First Myocardial Infarction

Diabetes care, 1998-01, Vol.21 (1), p.69-75

1998

Volltextzugriff (PDF)

Hyperinsulinemia and the risk of stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study

Stroke (1970), 1998-09, Vol.29 (9), p.1860-1866

1998

Volltextzugriff (PDF)

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering

The American journal of cardiology, 2000-08, Vol.86 (3), p.257-262

2000

Volltextzugriff (PDF)

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

Diabetologia, 2004-12, Vol.47 (12), p.2118-2128

2004

Volltextzugriff (PDF)

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

Circulation (New York, N.Y.), 1998-04, Vol.97 (15), p.1453-1460

1998

Volltextzugriff (PDF)

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys

Diabetologia, 2004-07, Vol.47 (7), p.1257-1265

2004

Volltextzugriff (PDF)

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

European heart journal, 2000-09, Vol.21 (18), p.1502-1513

2000

Volltextzugriff (PDF)

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris : Findings from the Scandinavian Simvastatin Survival Study (4S)

Circulation (New York, N.Y.), 1997-12, Vol.96 (12), p.4211-4218

1997

Volltextzugriff (PDF)

Assessment of coronary heart disease risk in populations with different levels of risk

European heart journal, 2000-03, Vol.21 (5), p.348-350

PYORALA, K

2000

Volltextzugriff (PDF)

Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men

Journal of internal medicine, 2012-06, Vol.271 (6), p.581-588

2012

Volltextzugriff (PDF)

1 – 25 von 559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(422)
Mit Volltextzugriff
(327)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(414)
Science & Technology
(331)
Life Sciences & Biomedicine
(330)
Male
(306)
Female
(285)
Middle Aged
(268)
Biological And Medical Sciences
(212)
Medical Sciences
(204)
Adult
(190)
Aged
(157)
Cardiovascular System & Cardiology
(128)
Risk Factors
(122)
Cardiac & Cardiovascular Systems
(113)
Coronary Heart Disease
(100)
Cardiology. Vascular System
(86)
Heart
(84)
Endocrinopathies
(67)
Endocrine Pancreas. Apud Cells
(66)
Diabetes. Impaired Glucose Tolerance
(63)
Finland
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

Diabetes, prediabetes and cancer mortality

Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men : The 22-year follow-up results of the Helsinki Policemen Study

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme

Relationship between body mass index and mortality among Europeans

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men

Impact of Diabetes on Mortality After the First Myocardial Infarction

Hyperinsulinemia and the risk of stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris : Findings from the Scandinavian Simvastatin Survival Study (4S)

Assessment of coronary heart disease risk in populations with different levels of risk

Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men

Suchergebnisse filtern